Imfinzi (durvalumab) - AstraZeneca
Imjudo (tremelimumab-actl) - AstraZeneca
Yervoy (ipilimumab) - BMS
AiTan (rivoceranib) - Elevar Therapeutics
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
sorafenib - Generic mfg.
Lenvima (lenvatinib) - Eisai, Merck (MSD)
Avastin (bevacizumab) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
Cabometyx (cabozantinib tablet) - Exelixis
AiRuiKa (camrelizumab) - Elevar Therapeutics
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/42627365
 
Choong-Kun Lee; David Wai-Meng Tai; Joseph J Zhao; Joycelyn Jie Xin Lee; Kennedy Yao Yi Ng; Raghav Sundar; Suat Ying Lee; Sze Huey Tan; Wei Yu Chua; Yung-Yeh Su
 
Aug 22, 2026
 
Prev Next